Epigenetic profiling of cells following WM-1119 treatment
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
ChIP-seq analysis of MOLM-13 human leukemia cells treated with DMSO or WM-1119 for 4 days Overall design: KAT6A promotes AML differentiation block. To test the effect of KAT6A inhibition on the epigenetic program of AML cells, we utilized a small molecule inhibitor targeting KAT6A to treat MOLM-13 human AML cells and performed ChIP-seq.
创建时间：
2021-10-25
